According to the data included in Tenders Electronic Daily (‘TED’) [https://ted.europa.eu/en/.], with respect to medical devices, procurement procedures with an estimated value equal to or above EUR 5000000 net of VAT represent around 59 % of the total Union procurement market of medical devices. In addition, pursuant to Articles 6(8) and 8(1) of the IPI Regulation, any IPI measure could only affect the supply of medical devices originating in the PRC at the maximum level of 50 % of the total value of the contract, irrespective of the origin of the bidder. Moreover, unlike the system implemented by the PRC, an IPI measure, would not require additional restrictive features, such as burdensome approval procedures for the procurement of medical devices from the PRC or the imposition of sector-specific targets for the procurement of medical devices originating in the Union.
23 2. DETERMINATION OF THE IPI MEASURE › 2.1. Proportionality and adequacy of a possible IPI measure with regard to the identified measures and practices › 2.1.2. Proportionality of a possible IPI measure, Regulation (EU) 2025/1197
In forcesince 19 Jun 2025